Analyst Whit Mayo of Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY – Research Report), with a price target of $36.00. Whit Mayo has given his Buy rating due to a combination ...

Bain Capital is making a play for full control of Surgery Partners (NASDAQ:SGRY), throwing down a $25.75 per share all-cash offervaluing the surgical facility operator at $3.2 billion. With Bain ...

Bain Capital and its affiliates own approximately 39% of the Company’s outstanding common stock, based on the Schedule 13D/A filing dated January 28, 2025. A Special Committee of independent ...

(Reuters) -Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it does not already own for $25.75 apiece, a filing showed on ...

EXCLUSIVE: The adaptation of Booker Prize-winner Shuggie Bain has emerged as one of the BBC’s “stuck in limbo” projects as drama boss Lindsay Salt blames a “perfect storm” for the ...

Jan 28 (Reuters) - Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners (SGRY.O), opens new tab it does not already own for $25. ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The Labour government has tried and failed to reimpose a ban on consultancy firm Bain & Co working for the ...

TOKYO -- Japan's Mitsubishi Chemical Group has granted a first-refusal right to U.S. investment fund Bain Capital for the purchase of its pharmaceutical subsidiary Mitsubishi Tanabe Pharma ...

Bain Capital has promoted Ivano Sessa to be co-head of European private equity as the investment firm is shaking up its leadership ranks in the region. The 47-year-old Italian will help lead the ...